Prof. MUSTAFA CENGİZ

Publication Network

Articles 91

1. Does Adding Chemotherapy to Radiotherapy Improve Outcomes in Stage II Nasopharyngeal Carcinoma?

KAHVECIOĞLU A., YILMAZ M. T., MOHAMMADIPOUR S., SARI S. Y., CENGİZ M., GÜLLÜ İ., et al.

Türk Onkoloji Dergisi , vol.40, no.2, pp.112-119, 2025 (ESCI, Scopus, TRDizin)

2. Evaluating the impact of cardiac substructure dosimetric parameters on survival in lung cancer patients undergoing postoperative radiotherapy

Yilmaz M. T., HÜRMÜZ P., GÜRLEK E., YILDIZ D., CENGİZ M.

STRAHLENTHERAPIE UND ONKOLOGIE , no.4, pp.452-462, 2025 (SCI-Expanded, Scopus)

3. In Regard to Macchia et al

GÜRLEK E., YÜCE SARI S., GÜLTEKİN M., CENGİZ M., Yldzz F.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , no.5, 2025 (SCI-Expanded, Scopus)

4. Re-irradiation in progressive diffuse infiltrative pontine glioma in children and young adults

KAHVECİOĞLU A., CENGİZ M., AYDIN G. B., KUTLUK M. T., ÇOBAN ÇİFÇİ G., YAZICI G.

STRAHLENTHERAPIE UND ONKOLOGIE , 2025 (SCI-Expanded, Scopus)

5. STAT3 Expression in Organ-Preserved Laryngeal Carcinomas: Correlation with Treatment Resistance and Conventional Parameters

Bayir E. N., Han U., Bayir O., Isik S., SAYLAM G., Yazilitas D., et al.

HEAD & NECK PATHOLOGY , no.1, 2025 (ESCI)

6. Analysis of patients with parotid recurrence after parotid-sparing IMRT for nasopharyngeal carcinoma: case series and review of the literature

YÜCE SARI S., Yilmaz M. T., YAZICI G., Mohammadipour S., ÖZYİĞİT G., Gullu İ. H., et al.

STRAHLENTHERAPIE UND ONKOLOGIE , no.12, pp.1057-1065, 2024 (SCI-Expanded, Scopus)

7. Stereotactic radiotherapy for head and neck paragangliomas: How long should we wait for treatment response?

YAZICI G., KAHVECİOĞLU A., YÜCE SARI S., ÖZYİĞİT G., YILDIZ D., CENGİZ M.

Radiotherapy and Oncology , vol.195, 2024 (SCI-Expanded, Scopus)

8. Radiotherapy Results in Locally Advanced Sinonasal Cancer

DURU BİRGİ S., Akaguenduez O. O., DAĞDELEN M., YAZICI G., CANYILMAZ E., Bicakci B. C., et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.47, no.6, pp.279-288, 2024 (SCI-Expanded, Scopus)

9. Predicting Overall Survival for Patients Who Underwent Adjuvant Chemoradiotherapy for Gastric Cancer

Yilmaz M. T., HÜRMÜZ P., DAĞ O., YİĞİT E., Ozyure Y., AVCI H., et al.

RADIOTHERAPY AND ONCOLOGY , 2024 (SCI-Expanded, Scopus)

10. The Impact of Concurrent Chemotherapy on Stage II Nasopharyngeal Carcinoma

Yilmaz M. T., KAHVECİOĞLU A., Mohammadipour S., CENGİZ M., Gullu I., AKSOY S., et al.

RADIOTHERAPY AND ONCOLOGY , 2024 (SCI-Expanded, Scopus)

11. Enhanced Radiosensitivity with Hypericum Perforatum in Radiation-induced Radiodermatitis Rat Model

Yilmaz M. T., YEDEKÇİ F. Y., YÜCE SARI S., KURTULAN O., CENGİZ M., Zorlu F., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.39, pp.337-344, 2024 (ESCI, Scopus, TRDizin)

12. Esophageal Carcinoma in Children: Report of 2 Cases and a Review of the Literature

Coskun C., Kurucu N., Kutluk T., Oguz B., ORHAN D., Cengiz M., et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , vol.46, no.1, 2024 (SCI-Expanded, Scopus) Sustainable Development

13. Evaluation of efficacy of tumor-specific nanoliposomal radiosensitizer in radiotherapy

Karabuga M., ERDOĞAN S., Filikci K., Hazıroglu R., TUNCEL M., CENGİZ M.

Journal of Drug Delivery Science and Technology , vol.86, 2023 (SCI-Expanded, Scopus)

14. The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma

GÜVEN D. C., ERUL E., YILMAZ F., YAŞAR S., YILDIRIM H. Ç., ERCAN F., et al.

European Archives of Oto-Rhino-Laryngology , vol.280, no.5, pp.2471-2478, 2023 (SCI-Expanded, Scopus)

15. Post-induction lymph node delineation in nasopharyngeal cancer: A single-center experience.

Sari S., YİĞİT E., YAZICI G., GÜLLÜ İ. H., AKSOY S., ÖZYİĞİT G., et al.

Head & neck , vol.45, no.3, pp.612-619, 2023 (SCI-Expanded, Scopus) Sustainable Development

16. Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinoma

ERUL E., Guven D. C., ÖZBAY Y., ALTUNBULAK A. Y., KAHVECİOĞLU A., ERCAN F., et al.

Biomarkers in medicine , vol.17, no.2, pp.87-99, 2023 (SCI-Expanded, Scopus)

17. Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study

Guler O. C., Oymak E., YAZICI G., Akagunduz O. O., Cetinayak O., Erpolat P., et al.

Oncology Research , vol.31, no.3, pp.299-306, 2023 (SCI-Expanded, Scopus)

18. Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome

Efe C., Kulkarni A. V., Terziroli Beretta-Piccoli B., Magro B., Friedrich Staettermayer A., Cengiz M., et al.

HEPATOLOGY , vol.76, no.6, pp.1576-1586, 2022 (SCI-Expanded, Scopus) Sustainable Development

19. Stereotactic radiotherapy for adrenal metastases: a multi-institutional review of patient characteristics and outcomes. Turkish Society for Radiation Oncology SBRT Group Study (TROD SBRT 10-004)

ELMALI A., Akkus Yildirim B., CENGİZ M., YÜCE SARI S., Onal C. C., Berber T., et al.

ONCOLOGY RESEARCH AND TREATMENT , vol.45, pp.717-727, 2022 (SCI-Expanded, Scopus)

20. Every other day stereotactic radiation therapy for the treatment of uveal melanoma decreases toxicity

YAZICI G., KIRATLI H., ÖZYİĞİT G., Sari S., Elmali A., Yilmaz M. T., et al.

RADIOTHERAPY AND ONCOLOGY , vol.176, pp.39-45, 2022 (SCI-Expanded, Scopus)

21. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis

Efe C., Taşçılar K., Gerussi A., Bolis F., Lammert C., Ebik B., et al.

Journal of Autoimmunity , vol.132, 2022 (SCI-Expanded, Scopus)

22. Turkish translation and validation of the Xerostomia Inventory

Sari S., Yilmaz M. T., ELMALI A., KILIÇ L., YÜCE D., ÖZYİĞİT G., et al.

ARCHIVES OF RHEUMATOLOGY , vol.37, pp.351-360, 2022 (SCI-Expanded, Scopus, TRDizin)

23. Assessment of Cardiac Autonomic Functions by Heart Rate Recovery Indices in Patients Receiving Chest Radiotherapy

Fatihoglu S. G., KAYA E. B., Kocyigit D., Hosrovzade E., Maharjan N., YAZICI G., et al.

EUROPEAN JOURNAL OF THERAPEUTICS , vol.28, no.2, pp.128-134, 2022 (ESCI, TRDizin)

24. Stereotactic body radiotherapy optimization to reduce the risk of carotid blowout syndrome using normal tissue complication probability objectives

Szalkowski G., Karakas Z., CENGİZ M., Schreiber E., Das S., YAZICI G., et al.

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS , vol.23, 2022 (SCI-Expanded, Scopus) Sustainable Development

25. Definitive Chemoradiotherapy Results in Synchronous Oligometastatic Non-small Cell Lung Cancer Patients Turkish Society for Radiation Oncology Group Study (TROD 10-003)

DURU BİRGİ S., Akgun Z., HÜRMÜZ P., AKYÜREK S., Saglam E. K., YILMAZ M. T., et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.45, no.1, pp.40-47, 2022 (SCI-Expanded, Scopus) Sustainable Development

26. Do grape and black mulberry molasses have an effect on oral mucositis and quality of life in patients with head and neck cancer?

Sari S., BEDÜK ESEN Ç. S., YAZICI G., YÜCE D., CENGİZ M., ÖZYİĞİT G.

SUPPORTIVE CARE IN CANCER , vol.30, no.1, pp.327-336, 2022 (SCI-Expanded, Scopus) Sustainable Development

27. Factors affecting post-treatment radiation-induced lung disease in patients receiving stereotactic body radiotherapy to lung

HÜRMÜZ P., CENGİZ M., Esen C. S. B., Yedekci Y., YILDIZ Z., ÖZYİĞİT G., et al.

Radiation and Environmental Biophysics , vol.60, pp.87-92, 2021 (SCI-Expanded, Scopus) Sustainable Development

28. Neoadjuvant Radiotherapy in Rectal Cancer: A Single Center Experience

HÜRMÜZ P., TİLKİ B., CENGİZ M., YILDIZ F., ÖZYİĞİT G., EROL T., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.3, pp.178-184, 2021 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

29. Stereotactic Radiosurgery and Fractionated Stereotactic Radiosurgery in Patients with Recurrent Glial Tumors

Eren G., Zorlu F., YAZICI G., CENGİZ M.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.4, pp.255-263, 2021 (SCI-Expanded, Scopus, TRDizin)

30. Impact of Seizures and Anti-epileptic Drug Use on Survival in Patients with World Health Organization Grade II Glioma

YÜCE SARI S., Caglar A., YAZICI G., CENGİZ M., Zorlu F.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.36, no.2, pp.206-214, 2021 (ESCI, Scopus, TRDizin)

31. A systematic review and practical considerations of stereotactic body radiotherapy in the treatment of head and neck cancer

Iqbal M. S., West N., Richmond N., Kovarik J., Gray I., Willis N., et al.

BRITISH JOURNAL OF RADIOLOGY , vol.94, no.1117, 2021 (SCI-Expanded, Scopus)

32. Stereotactic body radiotherapy in patients with early-stage non-small cell lung cancer: Does beam-on time matter?

HÜRMÜZ P., CENGİZ M., ÖZYİĞİT G., Akkas E. A., YÜCE D., YILMAZ M. T., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , vol.50, no.10, pp.1182-1187, 2020 (SCI-Expanded, Scopus)

33. Outcome of Elderly Nasopharyngeal Carcinoma Patients: A Single Center Study

Basaran H., CENGİZ M., YAZICI G., Ozdemir Y., SÜTAY SÜSLÜ N., GÜLLÜ İ. H., et al.

EUROPEAN JOURNAL OF THERAPEUTICS , vol.26, no.2, pp.129-134, 2020 (ESCI, TRDizin)

34. Stereotactic ablative radiotherapy for bone metastasis of gastrointestinal stromal tumor: Case report and review of the literature

YILMAZ M. T., GÜLTEKİN M., YALÇIN Ş., TUNCEL M., Gedikoglu G., YILDIZ F., et al.

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY , vol.25, no.3, pp.331-335, 2020 (ESCI, Scopus)

35. Validation of the EORTC-QLQ-HN35 Questionnaire in Turkish Head and Neck Cancer Patients

YÜCE SARI S., BEDÜK ESEN Ç. S., YÜCE D., CENGİZ M., ÖZYİĞİT G., YAZICI G.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.35, no.2, pp.144-149, 2020 (ESCI, Scopus, TRDizin)

36. Hypofractionated radiotherapy for non-metastatic bone and soft tissue sarcomas

SARI S., CENGİZ M., Dauletkazin A., YAZICI G., GÜLTEKİN M., HÜRMÜZ P., et al.

CANCER RADIOTHERAPIE , vol.23, no.8, pp.853-859, 2019 (SCI-Expanded, Scopus)

37. Long Term Follow-Up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer In Regard to Videtic et al

YILMAZ M. T., HÜRMÜZ P., CENGİZ M.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.104, no.2, pp.466-467, 2019 (SCI-Expanded, Scopus)

38. The role of ABO blood groups in glial neoplasms

Alkan A., YAZICI G., CENGİZ M., Karakas Y., ÇELİK İ., Kars A., et al.

BRITISH JOURNAL OF NEUROSURGERY , vol.33, no.1, pp.43-46, 2019 (SCI-Expanded, Scopus)

39. Current Status and Future Aspects of Stereotactic Body Radiotherapy and Immunotherapy in the Management of Recurrent Head and Neck Cancer

ÖZYİĞİT G., YÜCE SARI S., YAZICI G., CENGİZ M.

TURK ONKOLOGI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.34, no.4, pp.313-320, 2019 (ESCI, Scopus, TRDizin) Sustainable Development

40. The Synergistic Effect of Immune Checkpoint Blockade and Radiotherapy in Recurrent/Metastatic Sinonasal Cancer

YAZICI G., GÜLLÜ İ. H., CENGİZ M., ELMALI DOĞAN A., YILMAZ M. T., AKSOY S., et al.

Cureus , vol.10, pp.3519, 2018 (ESCI)

41. Human papillomavirus infection in patients with laryngeal carcinoma

Celebi O. O., Sener E., Hosal S., CENGİZ M., Gullu İ. H., Tezel G. G.

BMC CANCER , vol.18, 2018 (SCI-Expanded, Scopus) Sustainable Development

42. Fitting NTCP models to SBRT dose and carotid blowout syndrome data

Mavroidis P., Grimm J., CENGİZ M., Das S., Tan X., YAZICI G., et al.

MEDICAL PHYSICS , vol.45, no.10, pp.4754-4762, 2018 (SCI-Expanded, Scopus)

43. Concurrent Immune Checkpoint Inhibitors and Radiation Therapy

YILMAZ M. T., HÜRMÜZ P., CENGİZ M.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.101, no.4, pp.998, 2018 (SCI-Expanded, Scopus)

44. Reirradiation for Recurrent Pediatric Central Nervous System Malignancies

GÜLTEKİN M., Sari S., CENGİZ M.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.101, no.1, pp.235-236, 2018 (SCI-Expanded, Scopus)

45. Update of a Prospective Study of Stereotactic Body Radiation Therapy for Post-Chemoradiation Residual Disease in Stage II/III Non-Small Cell Lung Cancer

HÜRMÜZ P., CENGİZ M., Zorlu F., Akyol F.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.100, no.4, pp.1079-1080, 2018 (SCI-Expanded, Scopus) Sustainable Development

46. Stereotactic Re-irradiation for Recurrent or Second Primary Head-and-Neck Cancer

Unal I., CENGİZ M.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.33, no.1, pp.38-41, 2018 (ESCI, Scopus, TRDizin)

47. Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis

Efe C., Hagstrom H., Ytting H., Bhanji R. A., Muller N. F., Wang Q., et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.15, no.12, pp.1950-1957, 2017 (SCI-Expanded, Scopus)

48. Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers

Karam I., Yao M., Heron D. E., Poon I., Koyfman S. A., Yom S. S., et al.

FUTURE ONCOLOGY , vol.13, no.7, pp.603-613, 2017 (SCI-Expanded, Scopus) Sustainable Development

49. The role of delineation education programs for improving interobserver variability in target volume delineation in gastric cancer

Onal C., CENGİZ M., Guler O. C., Dolek Y., ÖZKÖK S.

BRITISH JOURNAL OF RADIOLOGY , vol.90, no.1073, 2017 (SCI-Expanded, Scopus)

50. The effect of leg position on the dose distribution of intracavitary brachytherapy for cervical cancer: 3D computerised tomography plan evaluation and in vivo dosimetric study

CENGİZ M., Colak F., YILDIZ D., DOĞAN A., ÖZYİĞİT G., YILDIZ F., et al.

JOURNAL OF RADIOTHERAPY IN PRACTICE , vol.15, no.4, pp.341-345, 2016 (ESCI, Scopus) Sustainable Development

51. Detection of O6-methylguanine-DNA methyltransferase gene promoter region methylation pattern using pyrosequencing and the effect of methylation pattern on survival, recurrence, and chemotherapy sensitivity in patients with laryngeal cancer

Celebi O. O., Tezel G. G., Hosal A. S., CENGİZ M., GÜLLÜ İ. H., HAYRAN K. M.

PATHOLOGY RESEARCH AND PRACTICE , vol.212, no.5, pp.456-462, 2016 (SCI-Expanded, Scopus)

52. PREVENTION OF RADIATION-INDUCED RETINOPATHY WITH AMIFOSTINE IN WISTAR ALBINO RATS

Yildirim B. A., Cetin E., Topkan E., ÖZYİĞİT G., CENGİZ M., Surucu S., et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES , vol.35, no.7, pp.1458-1464, 2015 (SCI-Expanded, Scopus)

53. Angiotensin-converting enzyme for noninvasive assessment of liver fibrosis in autoimmune hepatitis

Efe C., Cengiz M., Kahramanoglu-Aksoy E., YILMAZ B., Ozseker B., Beyazit Y., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.27, no.6, pp.649-654, 2015 (SCI-Expanded, Scopus)

54. PET-CT guided curative conformal radiation therapy in limited stage small cell lung cancer

Ulger S., DEMİRCİ N. Y., Aydinkarahaliloglu E., Kahraman F. C., Ozmen O., Erdogan Y., et al.

JOURNAL OF THORACIC DISEASE , vol.7, no.3, pp.295-302, 2015 (SCI-Expanded, Scopus) Sustainable Development

55. Stereotaktik Hipofraksiyone Radyoterapinin Radyobiyolojisi

YÜCE SARI S., CENGİZ M.

Türkiye Klinikleri Radyasyon Onkolojisi Özel , vol.1, no.1, pp.10-16, 2015 (TRDizin)

56. The Comparison of Two Different 5.5 Fr Sphincterotomes for Selective Cannulation of the Common Bile Duct: A Prospective, Randomized Study

Ozaslan E., Purnak T., Efe C., Ozaslan N. G., Cengiz M.

DIGESTIVE DISEASES AND SCIENCES , vol.59, no.12, pp.3078-3084, 2014 (SCI-Expanded, Scopus)

57. Robotic Stereotactic Radiosurgery in Patients with Nasal Cavity and Paranasal Sinus Tumors

ÖZYİĞİT G., CENGİZ M., HÜRMÜZ P., YAZICI G., GÜLTEKİN M., Akyol F., et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT , vol.13, no.5, pp.409-413, 2014 (SCI-Expanded, Scopus)

58. Practice patterns for oropharyngeal cancer in radiation oncology centers of Turkey

Karakoyun-Celik O., Altun M., Olmezoglu A., Buyukpolat M. Y., Ozkok S., AKMANSU M., et al.

TUMORI , vol.100, no.3, pp.284-288, 2014 (SCI-Expanded, Scopus) Sustainable Development

59. Comparison of Chest Wall and Lymphatic Radiotherapy Techniques in Patients with Left Breast Carcinoma

GÜLTEKİN M., Karabuga M., YILDIZ F., ÖZYİĞİT G., CENGİZ M., Zorlu F., et al.

JOURNAL OF BREAST HEALTH , vol.10, no.2, pp.106-110, 2014 (ESCI)

60. High FDG uptake predicts poorer survival in locally advanced nonsmall cell lung cancer patients undergoing curative radiotherapy, independently of tumor size

Ulger S., Demirci N. Y., Eroglu F. N., Cengiz H. H., Tunc M., Tatci E., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.140, no.3, pp.495-502, 2014 (SCI-Expanded, Scopus) Sustainable Development

61. Lymphoepithelial Carcinoma of the Lower Lip: Report of a Case

GÜLTEKİN M., SARI S., Gunhan O., Hosal S., CENGİZ M., Gurkaynak M.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.24, no.1, pp.70-72, 2014 (SCI-Expanded, Scopus, TRDizin)

62. Determination of gonad doses during robotic stereotactic radiosurgery for various tumor sites

Zorlu F., Dugel G., ÖZYİĞİT G., HÜRMÜZ P., CENGİZ M., YILDIZ F., et al.

MEDICAL PHYSICS , vol.40, no.4, 2013 (SCI-Expanded, Scopus)

63. Health-related quality of life in high-grade glioma patients: a prospective single-center study

Yavas C., Zorlu F., ÖZYİĞİT G., Gurkaynak M., YAVAŞ G., YÜCE D., et al.

SUPPORTIVE CARE IN CANCER , vol.20, no.10, pp.2315-2325, 2012 (SCI-Expanded, Scopus)

64. Prospective assessment of health-related quality of life in patients with low-grade glioma A single-center experience

Yavas C., Zorlu F., ÖZYİĞİT G., Gurkaynak M., YAVAŞ G., YÜCE D., et al.

SUPPORTIVE CARE IN CANCER , vol.20, no.8, pp.1859-1868, 2012 (SCI-Expanded, Scopus) Sustainable Development

65. High daily fraction dose external radiotherapy for T1 glottic carcinoma: Treatment results and prognostic factors

GÜLTEKİN M., Ozyar E., CENGİZ M., ÖZYİĞİT G., HAYRAN K. M., Hosal S., et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , vol.34, no.7, pp.1009-1014, 2012 (SCI-Expanded, Scopus)

66. Impact of Prophylactic Cranial Irradiation Timing on Brain Relapse Rates in Patients With Stage IIIB None-Small-Cell Lung Carcinoma Treated With Two Different Chemoradiotherapy Regimens

Topkan E., Parlak C., Kotek A., Yuksel O., Cengiz M., Ozsahin M., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.83, no.4, pp.1264-1271, 2012 (SCI-Expanded, Scopus)

67. Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer

CENGİZ M., DOĞAN A., ÖZYİĞİT G., Erturk E., YILDIZ F., SELEK U., et al.

BRACHYTHERAPY , vol.11, no.2, pp.125-129, 2012 (SCI-Expanded, Scopus) Sustainable Development

68. Esophageal squamous cell carcinoma in children: A case presentation and review of an unusual entity

SÜTAY SÜSLÜ N., Senirli R. T., HOŞAL A. Ş., ÖZGEN MOCAN B., CENGİZ M.

INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY EXTRA , vol.7, no.2, pp.67-69, 2012 (ESCI, Scopus)

69. DOES SACRIFICING THE DEEP LOBE OF PAROTID GLAND PREVENT MARGINAL MISS? IN REGARD TO CHEN ET AL. (INT J RADIAT ONCOL BIOL PHYS 2011;80:1423-1429)

YAZICI G., CENGİZ M., YILDIZ F., ÖZYİĞİT G.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.82, no.4, pp.1321-1322, 2012 (SCI-Expanded, Scopus)

70. Evaluating The Clinicopathologic Characteristics and Survival Outcome of Breast Cancer Patients with Isolated Brain Metastases after Adjuvant Treatment or at Initial Diagnosis

Boruban C., Gulyer H., Altundag K., ARTAÇ M., Guler T., CENGİZ M.

EUROPEAN JOURNAL OF GENERAL MEDICINE , vol.9, no.4, pp.265-269, 2012 (ESCI, Scopus, TRDizin) Sustainable Development

71. Periaortitis, Coronary Vasculitis and Retro-Orbital Pseudotumor in a Patient with Immunoglobulin G4-Related Sclerosing Vasculitis

BİLGİN B., Yesilkaya Y., Turker B., Varan O., Aydin O., Isik M., et al.

TURKISH JOURNAL OF RHEUMATOLOGY , vol.27, no.1, pp.63-66, 2012 (SCI-Expanded, Scopus, TRDizin)

72. Utility of "Over D1" or D1 Nodal Dissections in Predicting Outcome of Patients with Gastric Adenocarcinoma Treated with Postoperative Concurrent Chemoradiotherapy

SELEK U., Zorlu F., ÖZYİĞİT G., HÜRMÜZ P., YALÇIN Ş., CENGİZ M.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.22, no.4, pp.233-238, 2012 (SCI-Expanded, Scopus, TRDizin)

73. Ifosfamide and Doxorubicin Combination Chemotherapy for Recurrent Nasopharyngeal Carcinoma Patients

ŞENER DEDE D., AKSOY S., CENGİZ M., Gullu İ. H., Altundag K.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.5, pp.2225-2228, 2012 (SCI-Expanded, Scopus)

74. Second osteosarcoma of mandible after rhabdomyosarcoma of the cheek

Kupeli S., VARAN A., AKYÜZ C., CENGİZ M., Oguz K. K., Gedikoglu G., et al.

INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY EXTRA , vol.6, no.1, pp.42-44, 2011 (ESCI, Scopus) Sustainable Development

75. OUTCOME AND PROGNOSTIC FACTORS IN OLFACTORY NEUROBLASTOMA: A RARE CANCER NETWORK STUDY

Ozsahin M., Gruber G., Olszyk O., Karakoyun-Celik O., Pehlivan B., Azria D., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.78, no.4, pp.992-997, 2010 (SCI-Expanded, Scopus) Sustainable Development

76. Periauricular mold brachytherapy

ERSU B., Tulunoglu I., CENGİZ M.

BRACHYTHERAPY , vol.9, no.3, pp.239-242, 2010 (SCI-Expanded, Scopus)

77. Permanent Pacemaker and Implantable Cardioverter Defibrillator Infections: Seven Years of Diagnostic and Therapeutic Experience of a Single Center

Cengiz M., OKUTUCU S., AŞÇIOĞLU HAYRAN S., Sahin A., Aksoy H., DEVECİ O. S., et al.

CLINICAL CARDIOLOGY , vol.33, no.7, pp.406-411, 2010 (SCI-Expanded, Scopus)

78. PERMANENT PACEMAKER AND IMPLANTABLE CARDIOVERTER DEFIBRILLATOR INFECTIONS: SEVEN YEARS OF DIAGNOSTIC AND THERAPEUTIC EXPERIENCE OF SINGLE CENTER

OKUTUCU S., CENGİZ M., Sahin A., KARAKULAK U. N., AŞÇIOĞLU HAYRAN S., KAYA E. B., et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY , vol.140, 2010 (SCI-Expanded, Scopus)

79. Merkel Cell Carcinoma in a Child

KÖKSAL Y., Toy H., TALİM B., Unal E., AKÇÖREN Z., CENGİZ M.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , vol.31, no.5, pp.359-361, 2009 (SCI-Expanded, Scopus)

80. Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastases

Dincer M., Altundag K., Harputluoglu H., AKSOY S., CENGİZ M., Gullu İ. H.

MEDICAL ONCOLOGY , vol.25, no.3, pp.356-359, 2008 (SCI-Expanded, Scopus) Sustainable Development

81. Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer: Three-dimensional computed tomography plan evaluation

CENGİZ M., Gurdalli S., SELEK U., YILDIZ F., Saglam Y., Ozyar E., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.70, no.2, pp.464-468, 2008 (SCI-Expanded, Scopus)

82. Boost dose back again in elderly

GÜLTEKİN M., SELEK U., ÖZYİĞİT G., CENGİZ M., Yavas O., YILDIZ F.

JOURNAL OF CLINICAL ONCOLOGY , vol.25, no.36, pp.5843-5844, 2007 (SCI-Expanded, Scopus)

83. Comment on "cranial location of level II lymph nodes in laryngeal cancer: Implications for elective nodal target volume delineation": In regard to Braam et al. (Int J Radiat Oncol Biol Phys 2007;67.462-468)

Ozyigit G., Selek U., Cengiz M., Yildiz F.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.68, no.5, pp.1582-1583, 2007 (SCI-Expanded, Scopus)

84. Hormone receptor status as an independent variable affecting the survival of advanced breast cancer patients with brain metastases

Harputluoglu H., Cengiz M., Attundag K.

RADIOTHERAPY AND ONCOLOGY , vol.82, no.3, pp.356-357, 2007 (SCI-Expanded, Scopus) Sustainable Development

85. Change in blood chemistry may explain higher toxicity of total body irradiation for bone marrow transplantation

Cengiz M., Cetin E., Yildiz F., Selek U., Aydinkarahaliloglu E.

MEDICAL HYPOTHESES , vol.68, no.3, pp.554-557, 2007 (SCI-Expanded, Scopus)

86. The relationship between occupations and head and neck cancers

Pinar T., Akdur R., Tuncbilek A., Altundag K., Cengiz M.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , vol.99, no.1, pp.64-68, 2007 (SCI-Expanded, Scopus) Sustainable Development

87. Successful use of intraventricular and intravenous rituximab therapy for refractory primary CNS lymphoma in a child

Akyuz C., AYDIN G. B., Cila A., Akalan N., Soylemezoglu F., Cengiz M., et al.

LEUKEMIA & LYMPHOMA , vol.48, no.6, pp.1253-1255, 2007 (SCI-Expanded, Scopus)

88. Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer

Cengiz M., Zorlu F., Yalcin S., Gurkaynak M., Atahan I. L., Gullu İ. H.

MEDICAL ONCOLOGY , vol.24, no.2, pp.239-243, 2007 (SCI-Expanded, Scopus) Sustainable Development

89. Concomitant use of antioxidants may decrease the efficacy of cisplatin in cancer patients

Purnak T., Cengiz M., Altundag K.

MEDICAL HYPOTHESES , vol.68, no.5, pp.1177, 2007 (SCI-Expanded, Scopus) Sustainable Development

90. Increased expression of cyclooxygenase-2 (COX-2) in radiation-induced small bowel injury in rats

Keskek M., Gocmen E., Kilic M., Gencturk S., Can B., Cengiz M., et al.

JOURNAL OF SURGICAL RESEARCH , vol.135, no.1, pp.76-84, 2006 (SCI-Expanded, Scopus) Sustainable Development

91. Radiotherapy in the management of Kaposi's sarcoma: Comparison of 8 Gy versus 6 Gy

Yildiz F., Genc M., Akyurek S., Cengiz M., Ozyar E., Selek U., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , vol.98, no.7, pp.1136-1139, 2006 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 33

1. Reirradiation with Stereotactic Ablative Radiotherapy in Recurrent Nasopharyngeal Carcinoma

Yilmaz M. T., YİĞİT E., KAHVECİOĞLU A., YEDEKÇİ F. Y., YÜCE SARI S., CENGİZ M., et al.

9th International Congress on Innovative Approaches in Head and Neck Oncology (ICHNO), Barcelona, Spain, 21 - 23 March 2024, (Summary Text)

2. Reirradiation With Stereotactic Ablative Radiotherapy In Recurrent Head And Neck Cancers

YİĞİT E., Yilmaz M. T., KAHVECİOĞLU A., YEDEKÇİ F. Y., YÜCE SARI S., CENGİZ M., et al.

9th International Congress on Innovative Approaches in Head and Neck Oncology (ICHNO), Barcelona, Spain, 21 - 23 March 2024, (Summary Text)

3. Baş-boyun Radyoterapisi Sonrası Görülen Ağız Kuruluğunda Parotis Kök Hücrelerinin Önemi.

YÜCE SARI S., ELMALI A., YILMAZ M. T., YEDEKÇİ F. Y., YÜCE D., ÖZYİĞİT G., et al.

UROK 2021, Antalya, Turkey, 26 - 30 November 2021, (Summary Text)

4. Importance of Parotid Stem Cells in Xerostomia after Head and Neck Radiotherapy

YÜCE SARI S., ELMALI A., YILMAZ M. T., YEDEKÇİ F. Y., YÜCE D., ÖZYİĞİT G., et al.

ASTRO 2020, United States Of America, 24 - 28 October 2020, vol.108, pp.723-724, (Summary Text)

5. Definitive Chemoradiotherapy in Esophageal Squamous Cell Cancer: A Single Center Experience

YILMAZ M. T., HÜRMÜZ P., CENGİZ M., YÜCE D., ZORLU A. F., AKYOL H. F., et al.

9th International Gastrointestinal Cancer Conference, İstanbul, Turkey, 6 - 08 December 2019 Sustainable Development

6. DEFİNİTİVE CHEMORADİOTHERAPY İN ESOPHAGEAL S@UAMOUS CELL CANCER A SİNGLE CENTER EXPERİENCE

HÜRMÜZ P., CENGİZ M., YÜCE D., ZORLU A. F., AKYOL H. F., YALÇIN Ş., et al.

9 th international gastrointestinal cancer conference, 6 - 08 December 2019, (Full Text) Sustainable Development

7. non-operative management of rectal cancer: hacettepe university experience

TİLKİ B., HÜRMÜZ P., CENGİZ M., ZORLU A. F., ÖZYİĞİT G., YILDIZ F., et al.

9th international gastrointestinal cancer conference, 6 - 08 December 2019, (Full Text) Sustainable Development

8. A Single Center Experience of Neoadjuvant Radiotherapy in Rectal Cancer

HÜRMÜZ P., TİLKİ B., CENGİZ M., YILDIZ F., ÖZYİĞİT G., EROL T., et al.

6th CONGRESS OF THEMEDITERRANEAN MULTIDISCIPLINARY ONCOLOGY FORUM3rd INTERNATIONAL CONGRESS ON ONCOLOGICAL SCIENCES, 27 November - 01 December 2019, vol.5, (Full Text) Sustainable Development

9. The Role of Radiotherapy /- Chemotherapy in the treatment of Rectal Cancer: Single Center Experience

TİLKİ B., HÜRMÜZ P., CENGİZ M., YILDIZ F., ZORLU A. F., ÖZYİĞİT G., et al.

6th CONGRESS OF THEMEDITERRANEAN MULTIDISCIPLINARY ONCOLOGY FORUM3rd INTERNATIONAL CONGRESS ON ONCOLOGICAL SCIENCES, 27 November - 01 December 2019, vol.5, (Full Text) Sustainable Development

10. Results of Reirradiation with Stereotactic Radiotherapy in Recurrent Head and Neck Cancer

YÜCE SARI S., CENGİZ M., ELMALI DOĞAN A., YILMAZ M. T., YAZICI G., ÖZYİĞİT G.

ASTRO 2019, 15 - 18 September 2019, (Summary Text) Sustainable Development

11. Adjuvan Yoğunluk Ayarlı Radyoterapi Uygulanan Baş-Boyun Kanserli Olgularda Tedavi Sonuçlarımız.

YÜCE SARI S., CENGİZ M., YAZICI G., ELMALI DOĞAN A., BEDÜK Ç. S., GÜLLÜ İ. H., et al.

13.Ulusal Radyasyon Onkolojisi Kongresi, Turkey, 27 April - 01 May 2018, (Full Text) Sustainable Development

12. Baş-Boyun Melanomlarında Radyoterapi Sonuçlarımız

YÜCE SARI S., YAZICI G., CENGİZ M., YILMAZ M. T., AKSOY S., GÜLLÜ İ. H., et al.

13. ULUSAL RADYASYON ONKOLOJİSİ KONGRESİ, Turkey, 27 April - 01 May 2018, (Full Text)

13. Survival and Larynx Preservation Rates after Definitive Radiotherapy A Single Center Experience

CENGİZ M., YÜCE SARI S., GÜLTEKİN M., SÜSLÜ N., AKSOY S., KUŞCU O., et al.

ECHNO 2016, Budapest, Hungary, 7 - 10 September 2016, (Summary Text)

14. Results of Reirradiation with Stereotactic Radiotherapy in Recurrent Head and Neck Cancer

YÜCE SARI S., CENGİZ M., YAZICI G., ÖZYİĞİT G., kıvanç h., YILDIZ D., et al.

RADIOSURGERY SOCIETY MEETING 2016, ORLANDO, United States Of America, 16 - 18 June 2016, (Summary Text) Sustainable Development

15. Radiotherapy is as Effective as Surgery in terms of Local Control in Patients with Uveal Melanoma

YAZICI G., ÖZYİĞİT G., YÜCE SARI S., KIRATLI H., CENGİZ M., ZORLU A. F.

RADIOSURGERY SOCIETY MEETING 2016, ORLANDO, United States Of America, 16 - 18 June 2016, (Summary Text)

16. The Role of Fractionated Stereotactic Radiotherapy in the Primary Treatment of Optic Glioma and Meningioma

YÜCE SARI S., YAZICI G., ÖZYİĞİT G., ÖZGEN MOCAN B., CENGİZ M., ZORLU A. F.

RADIOSURGERY SOCIETY MEETING 2016, ORLANDO, United States Of America, 16 - 18 June 2016, (Summary Text)

17. Optik Gliom ve Menenjiom Tanılı Olguların Primer Tedavisinde Fraksiyone Stereotaktik Radyoterapinin Yeri

YÜCE SARI S., YAZICI G., ÖZYİĞİT G., ÖZGEN MOCAN B., CENGİZ M., ZORLU A. F.

9. MULTİDİSİPLİNER NÖROONKOLOJİ SEMPOZYUMU, İstanbul, Turkey, 13 - 14 May 2016, (Summary Text)

18. Rekürren baş boyun kanserli olgularda stereotaktik radyoterapi ile reirradyasyon sonuçlarımız

BİLTEKİN F., YÜCE SARI S., CENGİZ M., YAZICI G., kıvanç h., YILDIZ D., et al.

12. UROK, Turkey, 20 - 24 April 2016, (Summary Text) Sustainable Development

19. Optik gliom ve menenjiom tanılı olguların primer tedavisinde fraksiyone stereotaktik radyoterapinin yeri

YÜCE SARI S., YAZICI G., ÖZYİĞİT G., ÖZGEN MOCAN B., CENGİZ M., ZORLU A. F.

12. UROK, Turkey, 20 - 24 April 2016, (Summary Text)

20. Comparison of three different induction regimen in nasopharyngeal cancer: CF versus DC versus DCF.

Kertmen N., Aksoy S., Cengiz M., Yazici G., Keskin O., Babacan T., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32, (Summary Text) Sustainable Development

21. Cyberknife Rabotik Cerrahi Ünitesinin Output Stabilitesi 5 Yıllık Klinik Deneyim

BİLTEKİN F., CENGİZ M., Yücel H., Eken S., DOĞAN A., YEĞİNER M., et al.

11. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 23 - 27 April 2014, vol.29, pp.330-331, (Summary Text)

22. Mikro MLC tabanlI dinamik YART uygulamalarında segment sayısının tedavi parametrelerine etkisinin incelenmesi

BİLTEKİN F., YÜCEL H., DURU BİRGİ S., EKEN S., YAZICI G., CENGİZ M., et al.

11. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 23 - 27 April 2014, vol.29, pp.272-273, (Summary Text)

23. Medikal Lineer Hızlandırıcıların Uzun Dönem Output Stabilitelerinin Değerlendirilmesi

BİLTEKİN F., Eken S., Yücel H., CENGİZ M., YEĞİNER M., DOĞAN A., et al.

11. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 23 - 27 April 2014, vol.29, pp.333-334, (Summary Text)

24. EP-1470: The output stability of CyberKnife robotic radiosurgery unit: 5 years clinical experience

BİLTEKİN F., CENGİZ M., Yücel H., Eken S., DOĞAN A., YEĞİNER M., et al.

ESTRO 33, Viyana, Austria, 4 - 08 April 2014, vol.111, pp.149-150, (Summary Text)

25. Notron kontaminasyonundan kaynakli esdeger dozun alan boyutuna bagimliliginin dozimetrik olarak incelenmesi

BİLTEKİN F., ÖZYİĞİT G., ZORLU A. F., ÇELİK D., AKYOL H. F., CENGİZ M., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 19 - 23 April 2012, (Summary Text)

26. 6 MV foton enerjisinde SRT/SRS ve YART uygulamalarindan kaynakli notron kontaminasyonunun dozimetrik olarak olculmesi

BİLTEKİN F., ÖZYİĞİT G., CENGİZ M., ÇELİK D., ZORLU A. F., YILDIZ F., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 19 - 24 April 2012, (Summary Text)

27. Kama filtresinden kaynaklanan notron kontaminasyonunun esdeger doza katkisinin 18 MV medikal lineer hizlandiricida BD-PND bubble dedektor kullanilarak olculmesi

BİLTEKİN F., ÖZYİĞİT G., ÇOLAK Ş., ÇELİK D., AKYOL H. F., CENGİZ M., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 19 - 23 April 2012, (Summary Text)

28. 9 MeV, 10 MeV, 15 MeV ve 18 MeV elektron enerjilerinde BD-PND bubble dedektor kullanilarak notron kontaminasyonu olcumu

BİLTEKİN F., ÖZYİĞİT G., YILDIZ F., ÇELİK D., CENGİZ M., AKYOL H. F., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 19 - 23 April 2012, (Summary Text)

29. Parotis bezi tumorlerinin tedavisinde konvansiyonel, uc boyutlu konformal ve yogunluk ayarli radyoterapi tekniklerinin karsilastirilmasi

BİLTEKİN F., ÇELİK D., YÜREKLİ A. F., ŞİŞECİOĞLU S., GHALION B. K., ABDELKADER A., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi, Turkey, 19 - 23 April 2012, (Summary Text)

30. 18 MV foton enerjisinde 3B-KRT ve YART teknigi ile tedavi planlamasi yapilan prostat kanserli hastalarda notron kontaminasyonundan kaynakli ikincil kanser riskinin degerlendirilmesi

BİLTEKİN F., ÖZYİĞİT G., AKYOL H. F., ÇELİK D., YILDIZ F., ZORLU A. F., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 19 - 23 April 2012, (Summary Text) Sustainable Development

Books 1

1. Gastrointestinal System Cancers

HÜRMÜZ P., YAZICI G., GÜLTEKİN M., YÜCE SARI S., CENGİZ M., ÖZYİĞİT G.

in: Radiation Oncology: A Case-Based Review, Gokhan Ozyigit, Ugur Selek, Editor, Springer International Publishing, Cham, pp.203-274, 2018

Metrics

Publication

180

Publication (WoS)

129

Publication (Scopus)

119

Citation (WoS)

1157

H-Index (WoS)

Citation (Scopus)

590

H-Index (Scopus)

Citation (TrDizin)

H-Index (TrDizin)

Citation (Sum Other)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Publications & Works

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

H-Index (Scopus)

Citation (TrDizin)

H-Index (TrDizin)

Citation (Sum Other)

Project

Thesis Advisory

Open Access